nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.171	0.329	CbGbCtD
Mefenamic acid—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0986	0.19	CbGbCtD
Mefenamic acid—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0907	0.175	CbGbCtD
Mefenamic acid—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0907	0.175	CbGbCtD
Mefenamic acid—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0688	0.132	CbGbCtD
Mefenamic acid—Acetylsalicylic acid—TP53—chronic obstructive pulmonary disease	0.00228	0.265	CrCbGaD
Mefenamic acid—Lumiracoxib—CYP1A2—chronic obstructive pulmonary disease	0.00117	0.135	CrCbGaD
Mefenamic acid—Diclofenac—CXCL8—chronic obstructive pulmonary disease	0.00113	0.131	CrCbGaD
Mefenamic acid—PTGS2—leg—chronic obstructive pulmonary disease	0.00107	0.187	CbGeAlD
Mefenamic acid—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.001	0.116	CrCbGaD
Mefenamic acid—AKR1C3—bronchus—chronic obstructive pulmonary disease	0.000647	0.113	CbGeAlD
Mefenamic acid—AKR1C3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000633	0.111	CbGeAlD
Mefenamic acid—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00211	CcSEcCtD
Mefenamic acid—AKR1C3—trachea—chronic obstructive pulmonary disease	0.000581	0.102	CbGeAlD
Mefenamic acid—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000578	0.00209	CcSEcCtD
Mefenamic acid—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000574	0.00208	CcSEcCtD
Mefenamic acid—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000574	0.00208	CcSEcCtD
Mefenamic acid—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00057	0.00206	CcSEcCtD
Mefenamic acid—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000567	0.00205	CcSEcCtD
Mefenamic acid—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00204	CcSEcCtD
Mefenamic acid—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000563	0.00204	CcSEcCtD
Mefenamic acid—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000563	0.00204	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000558	0.00202	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.00202	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000556	0.00201	CcSEcCtD
Mefenamic acid—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000551	0.002	CcSEcCtD
Mefenamic acid—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000551	0.00199	CcSEcCtD
Mefenamic acid—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00199	CcSEcCtD
Mefenamic acid—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00199	CcSEcCtD
Mefenamic acid—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00199	CcSEcCtD
Mefenamic acid—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000544	0.00197	CcSEcCtD
Mefenamic acid—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000543	0.00196	CcSEcCtD
Mefenamic acid—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.00196	CcSEcCtD
Mefenamic acid—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00054	0.00196	CcSEcCtD
Mefenamic acid—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00054	0.00196	CcSEcCtD
Mefenamic acid—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.00196	CcSEcCtD
Mefenamic acid—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00196	CcSEcCtD
Mefenamic acid—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00054	0.00195	CcSEcCtD
Mefenamic acid—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00054	0.00195	CcSEcCtD
Mefenamic acid—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00195	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00195	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00195	CcSEcCtD
Mefenamic acid—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00194	CcSEcCtD
Mefenamic acid—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00194	CcSEcCtD
Mefenamic acid—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.00192	CcSEcCtD
Mefenamic acid—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00192	CcSEcCtD
Mefenamic acid—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00192	CcSEcCtD
Mefenamic acid—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000529	0.00192	CcSEcCtD
Mefenamic acid—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00191	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000527	0.00191	CcSEcCtD
Mefenamic acid—Diclofenac—CYP1A1—chronic obstructive pulmonary disease	0.000527	0.0611	CrCbGaD
Mefenamic acid—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000527	0.00191	CcSEcCtD
Mefenamic acid—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000524	0.0019	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00188	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00188	CcSEcCtD
Mefenamic acid—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00188	CcSEcCtD
Mefenamic acid—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00188	CcSEcCtD
Mefenamic acid—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00188	CcSEcCtD
Mefenamic acid—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000518	0.00188	CcSEcCtD
Mefenamic acid—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00187	CcSEcCtD
Mefenamic acid—Infection—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00187	CcSEcCtD
Mefenamic acid—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00185	CcSEcCtD
Mefenamic acid—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.00185	CcSEcCtD
Mefenamic acid—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000509	0.00184	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000509	0.00184	CcSEcCtD
Mefenamic acid—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000509	0.00184	CcSEcCtD
Mefenamic acid—Diclofenac—CYP1A2—chronic obstructive pulmonary disease	0.000508	0.0589	CrCbGaD
Mefenamic acid—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000507	0.00184	CcSEcCtD
Mefenamic acid—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.00184	CcSEcCtD
Mefenamic acid—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00183	CcSEcCtD
Mefenamic acid—Infection—Montelukast—chronic obstructive pulmonary disease	0.000506	0.00183	CcSEcCtD
Mefenamic acid—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00183	CcSEcCtD
Mefenamic acid—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00183	CcSEcCtD
Mefenamic acid—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00181	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000498	0.0018	CcSEcCtD
Mefenamic acid—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000498	0.0018	CcSEcCtD
Mefenamic acid—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00179	CcSEcCtD
Mefenamic acid—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00178	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00178	CcSEcCtD
Mefenamic acid—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00177	CcSEcCtD
Mefenamic acid—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00176	CcSEcCtD
Mefenamic acid—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00176	CcSEcCtD
Mefenamic acid—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000485	0.00176	CcSEcCtD
Mefenamic acid—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000483	0.00175	CcSEcCtD
Mefenamic acid—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00175	CcSEcCtD
Mefenamic acid—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00173	CcSEcCtD
Mefenamic acid—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00173	CcSEcCtD
Mefenamic acid—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00047	0.0017	CcSEcCtD
Mefenamic acid—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.0017	CcSEcCtD
Mefenamic acid—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00169	CcSEcCtD
Mefenamic acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000467	0.00169	CcSEcCtD
Mefenamic acid—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00168	CcSEcCtD
Mefenamic acid—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.00168	CcSEcCtD
Mefenamic acid—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000463	0.00168	CcSEcCtD
Mefenamic acid—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000462	0.00167	CcSEcCtD
Mefenamic acid—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000462	0.00167	CcSEcCtD
Mefenamic acid—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00167	CcSEcCtD
Mefenamic acid—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000459	0.00166	CcSEcCtD
Mefenamic acid—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00166	CcSEcCtD
Mefenamic acid—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00166	CcSEcCtD
Mefenamic acid—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000458	0.00166	CcSEcCtD
Mefenamic acid—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000457	0.00165	CcSEcCtD
Mefenamic acid—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000456	0.00165	CcSEcCtD
Mefenamic acid—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000453	0.00164	CcSEcCtD
Mefenamic acid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.00163	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00162	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00162	CcSEcCtD
Mefenamic acid—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00162	CcSEcCtD
Mefenamic acid—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00161	CcSEcCtD
Mefenamic acid—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00161	CcSEcCtD
Mefenamic acid—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00161	CcSEcCtD
Mefenamic acid—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.0016	CcSEcCtD
Mefenamic acid—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.00044	0.0511	CrCbGaD
Mefenamic acid—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00159	CcSEcCtD
Mefenamic acid—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00158	CcSEcCtD
Mefenamic acid—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00158	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00158	CcSEcCtD
Mefenamic acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00157	CcSEcCtD
Mefenamic acid—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000433	0.00157	CcSEcCtD
Mefenamic acid—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00156	CcSEcCtD
Mefenamic acid—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000432	0.00156	CcSEcCtD
Mefenamic acid—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.00156	CcSEcCtD
Mefenamic acid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00043	0.00156	CcSEcCtD
Mefenamic acid—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.00155	CcSEcCtD
Mefenamic acid—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00155	CcSEcCtD
Mefenamic acid—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00155	CcSEcCtD
Mefenamic acid—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000428	0.00155	CcSEcCtD
Mefenamic acid—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00154	CcSEcCtD
Mefenamic acid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00154	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00154	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00154	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00153	CcSEcCtD
Mefenamic acid—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00152	CcSEcCtD
Mefenamic acid—AKR1C3—lung—chronic obstructive pulmonary disease	0.000417	0.073	CbGeAlD
Mefenamic acid—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000416	0.00151	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000416	0.00151	CcSEcCtD
Mefenamic acid—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00149	CcSEcCtD
Mefenamic acid—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00149	CcSEcCtD
Mefenamic acid—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00149	CcSEcCtD
Mefenamic acid—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00149	CcSEcCtD
Mefenamic acid—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00149	CcSEcCtD
Mefenamic acid—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00149	CcSEcCtD
Mefenamic acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00041	0.00148	CcSEcCtD
Mefenamic acid—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00147	CcSEcCtD
Mefenamic acid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00147	CcSEcCtD
Mefenamic acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00147	CcSEcCtD
Mefenamic acid—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000404	0.00146	CcSEcCtD
Mefenamic acid—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00146	CcSEcCtD
Mefenamic acid—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00146	CcSEcCtD
Mefenamic acid—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00146	CcSEcCtD
Mefenamic acid—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00146	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00145	CcSEcCtD
Mefenamic acid—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.00144	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ALB—chronic obstructive pulmonary disease	0.000398	0.0462	CrCbGaD
Mefenamic acid—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00143	CcSEcCtD
Mefenamic acid—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00141	CcSEcCtD
Mefenamic acid—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.0014	CcSEcCtD
Mefenamic acid—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.0014	CcSEcCtD
Mefenamic acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00138	CcSEcCtD
Mefenamic acid—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00135	CcSEcCtD
Mefenamic acid—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00135	CcSEcCtD
Mefenamic acid—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00133	CcSEcCtD
Mefenamic acid—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00133	CcSEcCtD
Mefenamic acid—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00132	CcSEcCtD
Mefenamic acid—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00036	0.0013	CcSEcCtD
Mefenamic acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00129	CcSEcCtD
Mefenamic acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00129	CcSEcCtD
Mefenamic acid—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00128	CcSEcCtD
Mefenamic acid—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000353	0.00128	CcSEcCtD
Mefenamic acid—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00127	CcSEcCtD
Mefenamic acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00126	CcSEcCtD
Mefenamic acid—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00126	CcSEcCtD
Mefenamic acid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00124	CcSEcCtD
Mefenamic acid—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00124	CcSEcCtD
Mefenamic acid—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00122	CcSEcCtD
Mefenamic acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00122	CcSEcCtD
Mefenamic acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00033	0.0012	CcSEcCtD
Mefenamic acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.0012	CcSEcCtD
Mefenamic acid—Salicylic acid—ALB—chronic obstructive pulmonary disease	0.000328	0.038	CrCbGaD
Mefenamic acid—Rash—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00119	CcSEcCtD
Mefenamic acid—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00119	CcSEcCtD
Mefenamic acid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00119	CcSEcCtD
Mefenamic acid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00119	CcSEcCtD
Mefenamic acid—Headache—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00118	CcSEcCtD
Mefenamic acid—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00118	CcSEcCtD
Mefenamic acid—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00118	CcSEcCtD
Mefenamic acid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00117	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000324	0.00117	CcSEcCtD
Mefenamic acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000324	0.00117	CcSEcCtD
Mefenamic acid—Rash—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00116	CcSEcCtD
Mefenamic acid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00116	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00116	CcSEcCtD
Mefenamic acid—Headache—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00115	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00114	CcSEcCtD
Mefenamic acid—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.00114	CcSEcCtD
Mefenamic acid—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000314	0.00114	CcSEcCtD
Mefenamic acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00113	CcSEcCtD
Mefenamic acid—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.00113	CcSEcCtD
Mefenamic acid—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.00112	CcSEcCtD
Mefenamic acid—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00112	CcSEcCtD
Mefenamic acid—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.00112	CcSEcCtD
Mefenamic acid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00112	CcSEcCtD
Mefenamic acid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00112	CcSEcCtD
Mefenamic acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00112	CcSEcCtD
Mefenamic acid—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00111	CcSEcCtD
Mefenamic acid—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000303	0.0011	CcSEcCtD
Mefenamic acid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00109	CcSEcCtD
Mefenamic acid—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.00108	CcSEcCtD
Mefenamic acid—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.00108	CcSEcCtD
Mefenamic acid—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000296	0.00156	CbGpPWpGaD
Mefenamic acid—Diclofenac—ALB—chronic obstructive pulmonary disease	0.000293	0.034	CrCbGaD
Mefenamic acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00106	CcSEcCtD
Mefenamic acid—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00105	CcSEcCtD
Mefenamic acid—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000289	0.00105	CcSEcCtD
Mefenamic acid—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00104	CcSEcCtD
Mefenamic acid—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.000287	0.0333	CrCbGaD
Mefenamic acid—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00104	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00102	CcSEcCtD
Mefenamic acid—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00102	CcSEcCtD
Mefenamic acid—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000278	0.0486	CbGeAlD
Mefenamic acid—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.001	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000275	0.00145	CbGpPWpGaD
Mefenamic acid—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.000995	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000274	0.00145	CbGpPWpGaD
Mefenamic acid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.00143	CbGpPWpGaD
Mefenamic acid—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000271	0.00143	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000269	0.00142	CbGpPWpGaD
Mefenamic acid—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000268	0.00141	CbGpPWpGaD
Mefenamic acid—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000266	0.0465	CbGeAlD
Mefenamic acid—Ketoprofen—ALB—chronic obstructive pulmonary disease	0.00026	0.0301	CrCbGaD
Mefenamic acid—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000931	CcSEcCtD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000255	0.00135	CbGpPWpGaD
Mefenamic acid—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.000922	CcSEcCtD
Mefenamic acid—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000921	CcSEcCtD
Mefenamic acid—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.000915	CcSEcCtD
Mefenamic acid—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000913	CcSEcCtD
Mefenamic acid—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000249	0.00131	CbGpPWpGaD
Mefenamic acid—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000246	0.0013	CbGpPWpGaD
Mefenamic acid—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000245	0.0428	CbGeAlD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000238	0.00126	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000238	0.00126	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000237	0.00125	CbGpPWpGaD
Mefenamic acid—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000855	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000236	0.00124	CbGpPWpGaD
Mefenamic acid—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000234	0.0409	CbGeAlD
Mefenamic acid—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000842	CcSEcCtD
Mefenamic acid—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00084	CcSEcCtD
Mefenamic acid—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000839	CcSEcCtD
Mefenamic acid—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000829	CcSEcCtD
Mefenamic acid—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000818	CcSEcCtD
Mefenamic acid—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000815	CcSEcCtD
Mefenamic acid—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000814	CcSEcCtD
Mefenamic acid—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000224	0.0392	CbGeAlD
Mefenamic acid—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00081	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000222	0.00117	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000221	0.00117	CbGpPWpGaD
Mefenamic acid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00116	CbGpPWpGaD
Mefenamic acid—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000797	CcSEcCtD
Mefenamic acid—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00022	0.00116	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00022	0.00116	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00116	CbGpPWpGaD
Mefenamic acid—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000219	0.0383	CbGeAlD
Mefenamic acid—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00115	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000218	0.00115	CbGpPWpGaD
Mefenamic acid—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000786	CcSEcCtD
Mefenamic acid—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000783	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—GC—chronic obstructive pulmonary disease	0.000215	0.00114	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000215	0.00113	CbGpPWpGaD
Mefenamic acid—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000214	0.0374	CbGeAlD
Mefenamic acid—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00077	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000767	CcSEcCtD
Mefenamic acid—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000763	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000211	0.00111	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000211	0.00111	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.00021	0.00111	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000209	0.0011	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000208	0.00109	CbGpPWpGaD
Mefenamic acid—PTGS1—trachea—chronic obstructive pulmonary disease	0.000205	0.0359	CbGeAlD
Mefenamic acid—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00074	CcSEcCtD
Mefenamic acid—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00074	CcSEcCtD
Mefenamic acid—Infection—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000736	CcSEcCtD
Mefenamic acid—Shock—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000729	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.0002	0.00106	CbGpPWpGaD
Mefenamic acid—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000723	CcSEcCtD
Mefenamic acid—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000719	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000198	0.00104	CbGpPWpGaD
Mefenamic acid—PTGS2—trachea—chronic obstructive pulmonary disease	0.000196	0.0344	CbGeAlD
Mefenamic acid—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000706	CcSEcCtD
Mefenamic acid—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000193	0.00102	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000193	0.00102	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000191	0.00101	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000191	0.00101	CbGpPWpGaD
Mefenamic acid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000674	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000185	0.000976	CbGpPWpGaD
Mefenamic acid—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00067	CcSEcCtD
Mefenamic acid—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000665	CcSEcCtD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000182	0.000957	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.000953	CbGpPWpGaD
Mefenamic acid—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000652	CcSEcCtD
Mefenamic acid—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000179	0.000944	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000644	CcSEcCtD
Mefenamic acid—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.000642	CcSEcCtD
Mefenamic acid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.000642	CcSEcCtD
Mefenamic acid—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000638	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—HDAC2—chronic obstructive pulmonary disease	0.000176	0.000925	CbGpPWpGaD
Mefenamic acid—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000633	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000175	0.000922	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000174	0.000916	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000173	0.000911	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000171	0.000902	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00061	CcSEcCtD
Mefenamic acid—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000168	0.000888	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000168	0.000886	CbGpPWpGaD
Mefenamic acid—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000605	CcSEcCtD
Mefenamic acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000605	CcSEcCtD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000167	0.000881	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000167	0.000881	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000167	0.000879	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000166	0.000873	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000165	0.000871	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000165	0.00087	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—KL—chronic obstructive pulmonary disease	0.000163	0.00086	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000163	0.000859	CbGpPWpGaD
Mefenamic acid—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000588	CcSEcCtD
Mefenamic acid—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000585	CcSEcCtD
Mefenamic acid—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000585	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000161	0.00085	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.000848	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.000841	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.000836	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000158	0.000832	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000157	0.00083	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000157	0.000827	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000156	0.00082	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000155	0.000816	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000152	0.0008	CbGpPWpGaD
Mefenamic acid—PTGS1—lung—chronic obstructive pulmonary disease	0.000148	0.0258	CbGeAlD
Mefenamic acid—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000531	CcSEcCtD
Mefenamic acid—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000146	0.000767	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.000766	CbGpPWpGaD
Mefenamic acid—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000524	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.000758	CbGpPWpGaD
Mefenamic acid—PTGS2—lung—chronic obstructive pulmonary disease	0.000141	0.0247	CbGeAlD
Mefenamic acid—AKR1C3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00014	0.00074	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000507	CcSEcCtD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000136	0.000717	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000136	0.000716	CbGpPWpGaD
Mefenamic acid—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00049	CcSEcCtD
Mefenamic acid—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000134	0.000707	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000132	0.000697	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00069	CbGpPWpGaD
Mefenamic acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000471	CcSEcCtD
Mefenamic acid—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000129	0.00068	CbGpPWpGaD
Mefenamic acid—Rash—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000467	CcSEcCtD
Mefenamic acid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000466	CcSEcCtD
Mefenamic acid—Headache—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000464	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000124	0.000654	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000123	0.00065	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000123	0.000648	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—ERBB3—chronic obstructive pulmonary disease	0.000122	0.000645	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000122	0.000641	CbGpPWpGaD
Mefenamic acid—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00044	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000121	0.000639	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00012	0.00063	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HDAC2—chronic obstructive pulmonary disease	0.000118	0.000623	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000118	0.00062	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.000616	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000116	0.000613	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000116	0.000609	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.000607	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000114	0.000602	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000113	0.000596	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000112	0.00059	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000111	0.000587	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000111	0.000583	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KL—chronic obstructive pulmonary disease	0.00011	0.000579	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000109	0.000575	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000108	0.000572	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000108	0.000567	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000107	0.000566	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000106	0.00056	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.000557	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000105	0.000556	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000104	0.000547	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NOS2—chronic obstructive pulmonary disease	0.000102	0.000538	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000101	0.000534	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.0001	0.000529	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.0001	0.000528	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.89e-05	0.000521	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.85e-05	0.000519	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—ALB—chronic obstructive pulmonary disease	9.78e-05	0.000516	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.78e-05	0.000516	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.64e-05	0.000508	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.56e-05	0.000504	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.51e-05	0.000501	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.42e-05	0.000497	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	9.4e-05	0.000495	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.38e-05	0.000494	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	9.38e-05	0.000494	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.35e-05	0.000493	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.72e-05	0.00046	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—SERPINE1—chronic obstructive pulmonary disease	8.59e-05	0.000453	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.56e-05	0.000451	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	8.34e-05	0.00044	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.27e-05	0.000436	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.24e-05	0.000435	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.24e-05	0.000434	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB3—chronic obstructive pulmonary disease	8.23e-05	0.000434	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NOS3—chronic obstructive pulmonary disease	8.2e-05	0.000432	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	8.18e-05	0.000431	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.16e-05	0.00043	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.04e-05	0.000424	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.95e-05	0.000419	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	7.79e-05	0.000411	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.69e-05	0.000405	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.66e-05	0.000404	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.65e-05	0.000403	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.65e-05	0.000403	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.59e-05	0.0004	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.5e-05	0.000395	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	7.44e-05	0.000392	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ALB—chronic obstructive pulmonary disease	7.18e-05	0.000378	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.11e-05	0.000375	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.1e-05	0.000374	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.94e-05	0.000366	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.92e-05	0.000365	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	6.87e-05	0.000362	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.87e-05	0.000362	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS2—chronic obstructive pulmonary disease	6.86e-05	0.000362	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.7e-05	0.000353	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.34e-05	0.000334	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	6.29e-05	0.000331	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.23e-05	0.000328	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.18e-05	0.000326	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.17e-05	0.000325	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	6.06e-05	0.000319	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.01e-05	0.000317	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SERPINE1—chronic obstructive pulmonary disease	5.78e-05	0.000305	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.76e-05	0.000304	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.74e-05	0.000303	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.68e-05	0.000299	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.63e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.57e-05	0.000293	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.55e-05	0.000292	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS3—chronic obstructive pulmonary disease	5.52e-05	0.000291	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.51e-05	0.000291	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.45e-05	0.000288	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—chronic obstructive pulmonary disease	5.42e-05	0.000286	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—chronic obstructive pulmonary disease	5.32e-05	0.00028	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.3e-05	0.000279	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.16e-05	0.000272	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.12e-05	0.00027	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.09e-05	0.000268	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.07e-05	0.000267	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.06e-05	0.000267	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.02e-05	0.000265	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.93e-05	0.00026	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ALB—chronic obstructive pulmonary disease	4.83e-05	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.72e-05	0.000249	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.67e-05	0.000246	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.62e-05	0.000244	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.62e-05	0.000244	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.61e-05	0.000243	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.58e-05	0.000242	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.49e-05	0.000236	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.26e-05	0.000224	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.14e-05	0.000218	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—chronic obstructive pulmonary disease	4.09e-05	0.000215	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	4.08e-05	0.000215	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.07e-05	0.000214	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.05e-05	0.000213	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.02e-05	0.000212	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.86e-05	0.000204	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.8e-05	0.0002	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KL—chronic obstructive pulmonary disease	3.79e-05	0.0002	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.75e-05	0.000198	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.72e-05	0.000196	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.67e-05	0.000193	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.65e-05	0.000192	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—chronic obstructive pulmonary disease	3.65e-05	0.000192	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—chronic obstructive pulmonary disease	3.58e-05	0.000189	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.55e-05	0.000187	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.5e-05	0.000185	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.43e-05	0.000181	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.38e-05	0.000178	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.31e-05	0.000174	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.27e-05	0.000172	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.26e-05	0.000172	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.13e-05	0.000165	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.1e-05	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.09e-05	0.000163	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.05e-05	0.000161	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.98e-05	0.000157	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.86e-05	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	2.84e-05	0.00015	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.82e-05	0.000149	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.78e-05	0.000147	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.78e-05	0.000147	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.75e-05	0.000145	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—chronic obstructive pulmonary disease	2.75e-05	0.000145	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.69e-05	0.000142	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.66e-05	0.00014	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.59e-05	0.000137	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.55e-05	0.000135	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.5e-05	0.000132	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.48e-05	0.000131	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.46e-05	0.000129	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000128	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	2.37e-05	0.000125	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.29e-05	0.000121	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.26e-05	0.000119	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000118	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.11e-05	0.000111	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.1e-05	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.1e-05	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.01e-05	0.000106	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2e-05	0.000105	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	2e-05	0.000105	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.92e-05	0.000101	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.91e-05	0.0001	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.87e-05	9.84e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.84e-05	9.7e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.72e-05	9.04e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.67e-05	8.8e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	8.57e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.6e-05	8.42e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.36e-05	7.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.3e-05	6.85e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.26e-05	6.65e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.24e-05	6.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.11e-05	5.83e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.06e-05	5.57e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	9.5e-06	5.01e-05	CbGpPWpGaD
